These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27236317)

  • 1. Site-specific analysis of advanced glycation end products in plasma proteins of type 2 diabetes mellitus patients.
    Greifenhagen U; Frolov A; Blüher M; Hoffmann R
    Anal Bioanal Chem; 2016 Aug; 408(20):5557-66. PubMed ID: 27236317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Proteins Modified by Advanced Glycation End Products (AGEs) Reveal Site-specific Susceptibilities to Glycemic Control in Patients with Type 2 Diabetes.
    Greifenhagen U; Frolov A; Blüher M; Hoffmann R
    J Biol Chem; 2016 Apr; 291(18):9610-6. PubMed ID: 26933035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive identification of glycated peptides and their glycation motifs in plasma and erythrocytes of control and diabetic subjects.
    Zhang Q; Monroe ME; Schepmoes AA; Clauss TR; Gritsenko MA; Meng D; Petyuk VA; Smith RD; Metz TO
    J Proteome Res; 2011 Jul; 10(7):3076-88. PubMed ID: 21612289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific tandem mass spectrometric detection of AGE-modified arginine residues in peptides.
    Schmidt R; Böhme D; Singer D; Frolov A
    J Mass Spectrom; 2015 Mar; 50(3):613-24. PubMed ID: 25800199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein modification by the degradation products of ascorbate: formation of a novel pyrrole from the Maillard reaction of L-threose with proteins.
    Nagaraj RH; Monnier VM
    Biochim Biophys Acta; 1995 Nov; 1253(1):75-84. PubMed ID: 7492603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycation sites of human plasma proteins are affected to different extents by hyperglycemic conditions in type 2 diabetes mellitus.
    Frolov A; Blüher M; Hoffmann R
    Anal Bioanal Chem; 2014 Sep; 406(24):5755-63. PubMed ID: 25074545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum advanced glycation endproducts are associated with left ventricular dysfunction in normal glucose metabolism but not in type 2 diabetes: The Hoorn Study.
    Linssen PB; Henry RM; Schalkwijk CG; Dekker JM; Nijpels G; Brunner-La Rocca HP; Stehouwer CD
    Diab Vasc Dis Res; 2016 Jul; 13(4):278-85. PubMed ID: 27190078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of plasma proteins at multiple stages of glycation and antioxidant status with erythrocyte oxidative stress in patients with type 2 diabetes.
    Tupe RS; Diwan AG; Mittal VD; Narayanam PS; Mahajan KB
    Br J Biomed Sci; 2014; 71(3):93-9; quiz 138. PubMed ID: 25265752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of free fatty acids correlate with type 2 diabetes mellitus.
    Spiller S; Blüher M; Hoffmann R
    Diabetes Obes Metab; 2018 Nov; 20(11):2661-2669. PubMed ID: 29943387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end-products and advanced oxidation protein products levels are correlates of duration of type 2 diabetes.
    Heidari F; Rabizadeh S; Rajab A; Heidari F; Mouodi M; Mirmiranpour H; Esteghamati A; Nakhjavani M
    Life Sci; 2020 Nov; 260():118422. PubMed ID: 32946914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis of the site specificity of glycation and carboxymethylation of ribonuclease.
    Brock JW; Hinton DJ; Cotham WE; Metz TO; Thorpe SR; Baynes JW; Ames JM
    J Proteome Res; 2003; 2(5):506-13. PubMed ID: 14582647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reading patterns of proteome damage by glycation, oxidation and nitration: quantitation by stable isotopic dilution analysis LC-MS/MS.
    Rabbani N; Thornalley PJ
    Essays Biochem; 2020 Feb; 64(1):169-183. PubMed ID: 32065835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of Specific Glycation Sites in Human Serum Albumin as Prospective Type 2 Diabetes Mellitus Biomarkers.
    Spiller S; Frolov A; Hoffmann R
    Protein Pept Lett; 2017; 24(10):887-896. PubMed ID: 28155619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Serum Advanced Glycation End Products Are Associated with Decreased Insulin Secretion in Patients with Type 2 Diabetes: A Brief Report.
    Okura T; Ueta E; Nakamura R; Fujioka Y; Sumi K; Matsumoto K; Shoji K; Matsuzawa K; Izawa S; Nomi Y; Mihara H; Otsuka Y; Kato M; Taniguchi SI; Yamamoto K
    J Diabetes Res; 2017; 2017():5139750. PubMed ID: 28695132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of advanced glycation end products and oxidation biomarkers for type 2 diabetes.
    Chiu CJ; Rabbani N; Rowan S; Chang ML; Sawyer S; Hu FB; Willett W; Thornalley PJ; Anwar A; Bar L; Kang JH; Taylor A
    Biofactors; 2018 May; 44(3):281-288. PubMed ID: 29718545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple Glycation Sites in Blood Plasma Proteins as an Integrated Biomarker of Type 2 Diabetes Mellitus.
    Soboleva A; Mavropulo-Stolyarenko G; Karonova T; Thieme D; Hoehenwarter W; Ihling C; Stefanov V; Grishina T; Frolov A
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31083443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and relative quantification of specific glycation sites in human serum albumin.
    Frolov A; Hoffmann R
    Anal Bioanal Chem; 2010 Jul; 397(6):2349-56. PubMed ID: 20496030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Concentrations of Advanced Glycation end Products, its Association With the Development of Diabetes Mellitus.
    Jiménez IU; Díaz-Díaz E; Castro JS; Ramos JP; León MC; Alvarado Ríos JA; Auriostigue Bautista JC; Correa-Rotter R; Aguilar Salinas CA; Larrea F
    Arch Med Res; 2017 May; 48(4):360-369. PubMed ID: 29157674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative screening of protein biomarkers of early glycation, advanced glycation, oxidation and nitrosation in cellular and extracellular proteins by tandem mass spectrometry multiple reaction monitoring.
    Ahmed N; Thornalley PJ
    Biochem Soc Trans; 2003 Dec; 31(Pt 6):1417-22. PubMed ID: 14641078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site specific modification of the human plasma proteome by methylglyoxal.
    Kimzey MJ; Kinsky OR; Yassine HN; Tsaprailis G; Stump CS; Monks TJ; Lau SS
    Toxicol Appl Pharmacol; 2015 Dec; 289(2):155-62. PubMed ID: 26435215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.